Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A S Duncombe

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1990
Requirements for the adoptive transfer of antibody responses to a priming antigen in manJ Z Wimperis, D Gottlieb, A S Duncombe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1989
Tumor necrosis factor mediates autocrine growth inhibition in a chronic leukemiaA S Duncombe, H E Heslop, M Turner, et al.
British Journal of Haematology|April 8, 1998
Acute leukaemia in Jehovah's WitnessesJ O Cullis, A S Duncombe, J M Dudley, et al.
Immunology|February 1, 1991
IL-4 acts as a homeostatic regulator of IL-2-induced TNF and IFN-gammaC Bello-Fernandez, P Oblakowski, A Meager, et al.
Blood|December 15, 1990
Immunity against Pseudomonas aeruginosa adoptively transferred to bone marrow transplant recipientsD J Gottlieb, S J Cryz, E Furer, et al.
Blood|September 1, 1990
Gamma-interferon and tumor necrosis factor production after bone marrow transplantation is augmented by exposure to marrow fibroblasts infected with cytomegalovirusA S Duncombe, A Meager, H G Prentice, et al.
Transplantation Proceedings|February 1, 1991
Interleukin-2 infusion after autologous bone marrow transplantation enhances hemopoietic regenerationH E Heslop, A S Duncombe, J E Reittie, et al.
British Journal of Haematology|February 1, 1991
Interleukin 2 infusion induces haemopoietic growth factors and modifies marrow regeneration after chemotherapy or autologous marrow transplantationH E Heslop, A S Duncombe, J E Reittie, et al.
Blood|June 1, 1992
Bone marrow transplant recipients have defective MHC-unrestricted cytotoxic responses against cytomegalovirus in comparison with Epstein-Barr virus: the importance of target cell expression of lymphocyte function-associated antigen 1 (LFA1)A S Duncombe, J E Grundy, P Oblakowski, et al.
Leukemia|March 25, 2017
Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLLD R Howard, T Munir, L McParland, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1990
Requirements for the adoptive transfer of antibody responses to a priming antigen in manJ Z Wimperis, D Gottlieb, A S Duncombe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1989
Tumor necrosis factor mediates autocrine growth inhibition in a chronic leukemiaA S Duncombe, H E Heslop, M Turner, et al.
British Journal of Haematology|April 8, 1998
Acute leukaemia in Jehovah's WitnessesJ O Cullis, A S Duncombe, J M Dudley, et al.
Immunology|February 1, 1991
IL-4 acts as a homeostatic regulator of IL-2-induced TNF and IFN-gammaC Bello-Fernandez, P Oblakowski, A Meager, et al.
Blood|December 15, 1990
Immunity against Pseudomonas aeruginosa adoptively transferred to bone marrow transplant recipientsD J Gottlieb, S J Cryz, E Furer, et al.
Blood|September 1, 1990
Gamma-interferon and tumor necrosis factor production after bone marrow transplantation is augmented by exposure to marrow fibroblasts infected with cytomegalovirusA S Duncombe, A Meager, H G Prentice, et al.
Transplantation Proceedings|February 1, 1991
Interleukin-2 infusion after autologous bone marrow transplantation enhances hemopoietic regenerationH E Heslop, A S Duncombe, J E Reittie, et al.
British Journal of Haematology|February 1, 1991
Interleukin 2 infusion induces haemopoietic growth factors and modifies marrow regeneration after chemotherapy or autologous marrow transplantationH E Heslop, A S Duncombe, J E Reittie, et al.
Blood|June 1, 1992
Bone marrow transplant recipients have defective MHC-unrestricted cytotoxic responses against cytomegalovirus in comparison with Epstein-Barr virus: the importance of target cell expression of lymphocyte function-associated antigen 1 (LFA1)A S Duncombe, J E Grundy, P Oblakowski, et al.
Leukemia|March 25, 2017
Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLLD R Howard, T Munir, L McParland, et al.
Pageof 3